These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10500653)

  • 21. Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients.
    Dudley CR;
    Transplant Proc; 2001; 33(1-2):1034-5. PubMed ID: 11267179
    [No Abstract]   [Full Text] [Related]  

  • 22. Rejection and tacrolimus conversion therapy in paediatric liver transplantation.
    Spada M; Corno V; Colledan M; Segalin A; Lucianetti A; Torre G; Riva S; Sonzogni A; Petz W; Gridelli B
    Transpl Int; 2000; 13 Suppl 1():S341-4. PubMed ID: 11112028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation.
    Sperschneider H;
    Transplant Proc; 2001; 33(1-2):1279-81. PubMed ID: 11267291
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).
    Van Buren D; Payne J; Geevarghese S; MacDonell R; Chapman W; Wright JK; Helderman JH; Richie R; Pinson CW
    Transplant Proc; 1998 Jun; 30(4):1401-2. PubMed ID: 9636566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppressant switching between cyclosporine and tacrolimus after liver transplantation.
    Hashikura Y; Kawasaki S; Matsunami H; Terada M; Ikegami T; Nakazawa Y; Watanabe M; Chisuwa H; Kamijima T; Takagi S; Makuuchi M
    Transplant Proc; 1996 Apr; 28(2):1034-5. PubMed ID: 8623218
    [No Abstract]   [Full Text] [Related]  

  • 26. Late-onset acute rejection after living donor liver transplantation.
    Akamatsu N; Sugawara Y; Tamura S; Keneko J; Matsui Y; Hasegawa K; Makuuchi M
    World J Gastroenterol; 2006 Nov; 12(41):6674-7. PubMed ID: 17075982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial.
    O'Grady JG; Burroughs A; Hardy P; Elbourne D; Truesdale A;
    Lancet; 2002 Oct; 360(9340):1119-25. PubMed ID: 12387959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transplantation for fulminant hepatic failure: comparing tacrolimus versus cyclosporine for immunosuppression and the outcome in elective transplants. European FK506 Liver Study Group.
    Devlin J; Williams R
    Transplantation; 1996 Nov; 62(9):1251-5. PubMed ID: 8932266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in hospital stay after liver transplantation.
    Harrison DM; Stewart AS; Koneru B; Holman MJ
    Transplant Proc; 1996 Apr; 28(2):896. PubMed ID: 8623451
    [No Abstract]   [Full Text] [Related]  

  • 30. Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation.
    Cavaillé-Coll MW; Elashoff MR
    Transplantation; 1998 Jan; 65(1):142-5. PubMed ID: 9448161
    [No Abstract]   [Full Text] [Related]  

  • 31. Experience with neoral cyclosporine through the oral route in liver transplantation.
    Bilbao I; Lazaro JL; Pou L; Charco R; Hildalgo E; Murio E; Margarit C
    Transplant Proc; 1998 Jun; 30(4):1432-4. PubMed ID: 9636580
    [No Abstract]   [Full Text] [Related]  

  • 32. Conversion from tacrolimus to Neoral in liver and kidney transplant recipients.
    Ott R; Bussenius-Kammerer M; Scholz D; Neuhaus R; Tolba RH; Fricke L; Müller V
    Transplant Proc; 2001; 33(7-8):3166-8. PubMed ID: 11750359
    [No Abstract]   [Full Text] [Related]  

  • 33. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indications for mycofenolate mofetil therapy after liver transplantation.
    Platz KP; Mueller AR; Neuhaus P
    Transplant Proc; 1997 Nov; 29(7):2880-1. PubMed ID: 9365601
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients.
    Van Buren D; Payne J; Geevarghese S; MacDonell R; Chapman W; Wright JK; Helderman JH; Richie R; Pinson CW
    Transplant Proc; 1998 Aug; 30(5):1830-2. PubMed ID: 9723299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
    Platz KP; Tullius SG; Mueller AR; Schumacher G; Nüssler N; Neuhaus R; Bechstein WO; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235
    [No Abstract]   [Full Text] [Related]  

  • 37. Tacrolimus in the prevention of graft rejection: new indication. Helpful alternative to ciclosporin.
    Prescrire Int; 1998 Aug; 7(36):108-9. PubMed ID: 10342948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrotoxicity associated with cyclosporine and FK506.
    Klintmalm GB; Gonwa TA
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):11-9. PubMed ID: 9346596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
    Reggiani P; Rossi G; Latham L; Caccamo L; Gatti S; Maggi U; Melada E; Paone G; Doglia M; Vannelli A; Fassati LR
    Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
    [No Abstract]   [Full Text] [Related]  

  • 40. Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506).
    Kramer MR; Merin G; Rudis E; Bar I; Nesher T; Bublil M; Milgalter E
    Transplant Proc; 1997 Sep; 29(6):2657-9. PubMed ID: 9290780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.